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Abstract
A small group of around 40 people came together at the Chancellors Conference
Centre in Manchester for the Ontologies Workshop, chaired by Alan Rector and
Robert Stevens. The workshop was, rather strangely, spread over 2 half days. In
hindsight, this programme worked very well as it gave people the opportunity
to chat over a drink on the Saturday evening and share ideas, before launching
into the second half on the following day. The participants were from various
walks of life, all with a common interest in ﬁnding out more about ontologies
and promoting collaborations between the medical informatics and bioinformatics
ontology communities. Copyright  2002 John Wiley & Sons, Ltd.
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Introduction
There are different ideas of what really makes an
ontology, but the common factor is that they are
all created as a container to capture knowledge
or information about a concept, organism, process,
etc. — the list is endless. Ontologies are a hier-
archical structuring of knowledge subcategorized
by their relevant qualities; controlled vocabular-
ies in the form of words or phrases are used in
ontologies to bring different meanings or synonyms
together under one clear term. By using controlled
vocabularies, we avoid using free text and make
our information understandable by computers. This
makes the task of parsing the information more
attainable, and can allow us to gain a shared under-
standing of disparate datasets through the use of
ontologies.
This conference brought together not only those
interested in the biology behind the ontologies,
but also the bioinformaticians wanting to develop
the tools to take things further and at a greater
speed.
Robert Stevens (University of Manchester)
started the proceedings by stating that in this
post-genomic phase we are no longer interested
in the smaller picture of single proteins; we
are now looking at populations of molecules
in relationship to their genotype and phenotype.
He asked colleagues of his, in advance of the
workshop, what they understood by the terms
‘genotype’ and ‘phenotype’. He found that there
was a reasonably tight understanding of ‘geno-
type’ as relating to regions of nucleic acid and
involving alleles, whereas the term ‘phenotype’
led to a vast array of examples, such as eye
colour, Mendel’s pea experiments, and disease. In
general, bioinformatics ontologies have described
the genotype of organisms, and phenotype has
been covered more by the medical informatics
ontologies (Robert Stevens Bio-ontology page:
http://img.cs.man.ac.uk/stevens/ontology.html).
Robert hopes that the linking of these ontologies
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can bring the two ﬁelds together in some interest-
ing collaborations.
Many questions were likely to arise from this
meeting, but as food for thought he put forward
the questions: What are the roles of ontologies?
What can be covered in the span of genotype to
phenotype? Can we re-use ontologies, e.g. use an
existing anatomy ontology as a template for a new
anatomy ontology for another species?
The use of controlled vocabularies to standard-
ize and provide consistency in databases was a
common theme in the talks. As more genomes
are studied, and sequenced faster than before,
there is a greater need for the glut of data
being produced to be managed efﬁciently, allow-
ing researchers to query the data more effectively.
Agreeing on terms to use is a vast task but will
ultimately lead to users knowing the best way
to query their data and other people’s. The use
of different synonyms, e.g. in the case of gene
names, can cause data to be ‘lost’ in databases,
so using a standard gene name makes sense. This
is what the HUGO Gene Nomenclature Commit-
tee (http://www.gene.ucl.ac.uk/nomenclature)i s
working on. Ruth Lovering (HUGO Gene No-
menclature Committee, UCL) described how the
HGNC make sure that unique and meaningful
gene symbols are assigned, promoting standard-
ization and consistency when describing genes.
When she presented their work, the updated ver-
sion of their guidelines was in press, but the
article has since been published (Wain et al.
2002). Once they have assigned a gene name
and gene symbol, the information is stored in the
Genew database (http://www.gene.ucl.ac.uk/cgi-
bin/nomenclature/searchgenes.pl), which also re-
ceives automatic updates from LocusLink, SWISS-
PROT, GDB and MGD. Genew contains over
14000 active gene symbols, is user-friendly and
easy to query.
The importance of consistent gene naming, or at
least keeping on top of gene name synonyms, was
clearly illustrated in Joyce Mitchell’s (National
Library of Medicine, USA) presentation. She has
been examining the coverage of the Uniﬁed Med-
ical Language System (UMLS; UMLS and Gene
Ontology navigators: http://etbsun2.nlm.nih.gov:
8000/), GO and LocusLink-OMIM and the prob-
lems faced ﬁnding terms stored in different resour-
ces when there are so many synonyms being used.
She presented a multitude of slides showing the
statistical results of her searches, which essen-
tially showed that a signiﬁcant number of gene
entries were not being retrieved. The main rea-
son behind the failure to ﬁnd many genes in these
databases was because no single source contained
all gene names and synonyms. Sometimes the
gene names have comments attached to the ofﬁcial
name, which prevents their retrieval. The message
coming through from her work was that improve-
ments in gene naming, and the storage of more
information on each gene, are required to solve
these problems.
Anne Westcott (AstraZeneca Pharmaceuti-
cals) presented the application of genotyping in
gene discovery and drug response typing. At
present, the whole process of target (gene) identi-
ﬁcation, candidate drug development, concept test-
ing, marketing, etc. can take 7–8 years; under-
standably they want to reduce this. The recent dis-
covery and mapping of a massive number of single
nucleotide polymorphisms (SNPs) and microsatel-
lites (that serve as genetic markers), and the abil-
ity to collect and archive DNA from clinical trial
subjects is bringing the concept of medicines tai-
lored to the individual within reach. Using these
resources could help pharmaceutical companies to
develop compounds that will be effective in the
majority of the population, or to identify the subset
of the population for whom a particular drug will
be effective and those in which it will cause side-
effects. For this to happen, they need larger col-
lections of DNA, better-characterized phenotypes,
pedigree data where appropriate and, rather impor-
tantly, reproducible results. This approach is going
to generate a large amount of trait-based informa-
tion that needs to be stored alongside sequence
data to allow comparisons between individuals or
groups.
Dieter Maier (Biomax Informatics AG, Ger-
many: http://www.biomax.de/) presented the Fun-
Cat controlled vocabulary, which covers biological
processes and molecular functions of proteins in
prokaryotes, unicellular eukaryotes, plants and ani-
mals. There are separate phenotype catalogues to
contain the information for normal and mutated
forms, as they do not want to mix these. FunCat
is hierarchically organized and has been used in
the manual and automated annotation of a range of
species.
The work of the Gene Ontology (GO) group
was mentioned by several of the speakers. This
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was often because their groups are part of the
GO Consortium (http://www.geneontology.org)
but mainly to acknowledge the great work being
carried out. Midori Harris (European Bioinfor-
matics Institute) explained that the GO project
covers three ontologies: molecular function, bio-
logical process and cellular component. In building
these ontologies to describe gene products and the
various aspects of molecular biology, they are using
controlled vocabularies that will, in turn, help in
developing tools to query the ontologies, and add
to them, as more is known.
Judith Blake (Jackson Laboratory, USA) from
the Mouse Genome Informatics group (Mouse
Genome Informatics: http://www.informatics.jax.
org), who are part of the GO Consortium (http://
www.geneontology.org), outlined three projects
being undertaken: Mouse Genome Database Project
(MGD), Gene Expression Database Project (GXD),
and Mouse Genome Sequence Project (MGS).
She highlighted their system as being a compre-
hensive resource containing details at the molec-
ular level, plus information pertaining to nor-
mal and dysfunctional phenotypes, for the mouse.
The relationships between these phenotypes and
those observed in humans are also stored. Their
phenotype ontology building is occurring whilst
annotation of the mouse data is still ongoing
and they support the use of controlled vocab-
ularies and furthering the scope of ontologies.
They are also in collaboration with the MRC
and Edinburgh Mouse Atlas Project (EMAP),
who are aiming to provide nomenclature for the
parts of the mouse anatomy from fertilization to
adult stage (Standard Anatomical Nomenclature
Database: http://genex.hgu.mrc.ac.uk/Databases/
Anatomy/), and provide 3-D anatomy reconstruc-
tions to view. Albert Burger (Heriot-Watt Uni-
versity) is a member of the team working on
EMAP and the Edinburgh Mouse Atlas Gene
Expression Database Project (EMAGE: http://
genex.hgu.mrc.ac.uk/). He showed slides demon-
strating the anatomy browser and then went on
to explain the thinking behind the building of
the anatomy ontology and the Edinburgh Anatomy
Mapping System (EdAMS). EdAMS is a cross-
species embryo anatomy system that stores con-
ﬁrmed mappings between tissues of different
species and will suggest potential mappings, based
on various rules, which need to be checked by edi-
tors to decide whether to reject or accept them.
An ontology for craniofacial abnormality re-
search was presented by Peter Hammond (Uni-
versity College London). He showed some fantas-
tic, lifelike 3-D images that are stored as a record of
a patient’s morphology. These images are needed
to fully capture a patient’s features from all views.
There is a need to re-scan over time due to natural
phenotypic changes, such as in the case of a child
ageing, or after surgery, which often causes a dra-
matic craniofacial change. In addition to an image
ontology they need ontologies to capture informa-
tion on the syndrome, the genetics of the patient,
plus any other relevant data.
Fouzia Moussouni (INSERM U522 and Med-
ical Informatics Laboratory, France) is working
on liver disorders relating to the metabolism of
iron. She is using microarrays to compare normal
and pathologic samples. She stressed the need for
an integrated gene expression warehouse to bring
together medical, genome and array data. She made
reference to the current standards in place which
can pave the way forward: minimum information
about a microarray experiment (MIAME: Brazma
et al., 2001); GO, an ontology for molecular biol-
ogy and genomics; and UMLS, an aid for health
professionals and researchers to use biomedical
information from different sources.
For small research groups the storage and min-
ing of microarray data is becoming a problem.
One possible solution is to use a public database.
Philippe Rocca-Serra (European Bioinformatics
Institute) presented the ArrayExpress database
(http://www.ebi.ac.uk/microarray/Array
Express/), which is just such a repository, designed
for gene expression data. Submission of data can
eitherbeviaMIAMExpress(http://www.ebi.ac.uk/
microarray/MIAMExpress/) or a direct submis-
sion in MAGE-ML format, an XML ﬁle format that
adheres to a speciﬁed content and order for microar-
ray gene expression experiments. The data held in
ArrayExpress is of a particular format and is curated
to ensure consistency in the terms used (controlled
vocabulary) across microarray experiments to allow
easy access to information. MIAME (Brazma et al.,
2001), developed by the Microarray Gene Expres-
sion Data (MGED) group (http://www.mged.org),
is a speciﬁcation of the minimum information
required from a microarray experiment to enable a
researcher to be able to duplicate the experiment
in his/her laboratory. The MIAME requirements
are, in brief: experimental design, array design,
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samples, hybridizations, measurements and normal-
ization controls. The information is annotated with
the use of ontologies, where possible, and at present
the MGED ontology working group is develop-
ing speciﬁc ontologies for describing experimental
conditions in gene expression experiments. Where
ontologies are not available, new ones will have to
be developed.
Stuart Aitken (University of Edinburgh) pre-
sented the Rapid Knowledge Formation (RKF)
project (http://www.aiai.ed.ac.uk/∼stuart/RKF/),
which aims to develop tools to enable expert biol-
ogists to construct an ontology by entering their
knowledge into a knowledge-based system. Biol-
ogists took part in a pilot project to test the tools
available; the knowledge they had to formalize was
from a chapter in Essential Cell Biology, by Alberts
et al. (1998). The results were evaluated and the
ontology was revised.
Alan Rector (University of Manchester) from
the Medical Informatics Group (http://www.cs.
man.ac.uk/mig), talked about logic-based ontolo-
gies, OIL and DAML+OIL being modern exam-
ples. Knowledge can be broken down into smaller
parts that can, with the correct terms linking them,
be understandable by both humans and computers.
There is still a long way to go and not every-
thing can be expressed in this way, but logic-based
ontologies can be used to a certain extent to model
biology.
Conclusion
It was clear from the presentations and from talking
to people at the meeting that there is a common
goal to use ontologies and to develop new ones
where a void exists. Delegates were also keen
to use controlled vocabularies, as they know that
consistency in annotation is needed to make data
mining more efﬁcient and to gain a common
understanding.
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